Serum iron metabolism markers including hepcidin in multiple sclerosis patients

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  I. Sadowska-Bartosz,et al.  Oxidative modification of serum proteins in multiple sclerosis , 2013, Neurochemistry International.

[3]  C. Wolfson,et al.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review , 2013, BMC Neurology.

[4]  Cris S Constantinescu,et al.  Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome , 2013, Multiple sclerosis.

[5]  G. D’Angelo,et al.  Role of hepcidin in the pathophysiology and diagnosis of anemia , 2013, Blood research.

[6]  F. Salvi,et al.  Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis , 2012, BMC Medical Genetics.

[7]  Roberta J. Ward,et al.  Brain iron metabolism and its perturbation in neurological diseases , 2011, Journal of Neural Transmission.

[8]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[9]  F. Barkhof,et al.  Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency , 2010, Neurology.

[10]  F. Salvi,et al.  Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. , 2010, International angiology : a journal of the International Union of Angiology.

[11]  C. Guttmann,et al.  Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[12]  J. Stankiewicz,et al.  Role of iron in neurotoxicity: a cause for concern in the elderly? , 2009, Current opinion in clinical nutrition and metabolic care.

[13]  D. Girelli,et al.  Immunoassay for human serum hepcidin. , 2008, Blood.

[14]  L. Rashed,et al.  The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study , 2008, Multiple sclerosis.

[15]  D. Dexter,et al.  Metal based neurodegenerative diseases - From molecular mechanisms to therapeutic strategies , 2008 .

[16]  G. Giovannoni,et al.  Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis , 2008, Multiple sclerosis.

[17]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.

[18]  O. von Bohlen und Halbach,et al.  Distribution of the iron‐regulating protein hepcidin in the murine central nervous system , 2006, Journal of neuroscience research.

[19]  R. Bakshi,et al.  Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.

[20]  C. W. Tjoa,et al.  MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.

[21]  E. Hatzimichael,et al.  Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients , 2005, Multiple sclerosis.

[22]  J. Sullivan.  Is stored iron safe? , 2004, The Journal of laboratory and clinical medicine.

[23]  S. LeVine,et al.  The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 2004, Annals of the New York Academy of Sciences.

[24]  C. Polman,et al.  Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. , 2002, Brain : a journal of neurology.

[25]  P. Adam,et al.  Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients , 2000, Acta neurologica Scandinavica.

[26]  S. Lynch,et al.  Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients , 1999, Brain Research.

[27]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[28]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[29]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[30]  Manjit,et al.  Neurology , 1912, NeuroImage.

[31]  J. Winn,et al.  Brain , 1878, The Lancet.

[32]  Z. Qian,et al.  Role of hepcidin in murine brain iron metabolism , 2009, Cellular and Molecular Life Sciences.